SCHEMBL21670909

SCHEMBL21670909

CN(I)[C@H]1Cc2ccc(OC(F)(F)F)cc2[C@]2(I)CCCC[C@H]12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 9/20 0.51
▸ SIGMAR1 Q99720 9/20 0.51
▸ TMEM97 Q5BJF2 5/20 0.51
▸ SLC6A3 Q01959 3/20 0.40
▸ GRIN1 Q05586 4/20 0.36
▸ GRIN2A Q12879 4/20 0.36
▸ CYP2D6 P10635 3/20 0.36
▸ SLC22A1 O15245 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ GRIN2D O15399 3/20 0.35
▸ GRIN3B O60391 3/20 0.35
▸ GRIN2B Q13224 3/20 0.35
▸ GRIN2C Q14957 3/20 0.35
▸ GRIN3A Q8TCU5 3/20 0.35
▸ SLC6A2 P23975 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ PMP22 Q01453 2/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24224451 0.74 SLC6A4 (0.49) SLC6A4SIGMAR1TMEM97SLC6A3GRIN1
SCHEMBL18460931 0.74 GRIN1 (0.49) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL24224567 0.68 SLC6A4 (0.40) SLC6A4SIGMAR1TMEM97SLC6A3
SCHEMBL10162816 0.67 SIGMAR1 (1.00) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL10163317 0.67 SIGMAR1 (1.00) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL17667804 0.67 SIGMAR1 (1.00) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL17773741 0.67 SIGMAR1 (1.00) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL24224548 0.66 SIGMAR1 (0.71) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL10163270 0.65 SIGMAR1 (0.86) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A
SCHEMBL10162806 0.65 SIGMAR1 (0.86) SLC6A4SIGMAR1TMEM97GRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3603674-A1 COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF INTRACTABLE AND CHRONIC PAIN CONCERT PHARMACEUTICALS, INC. (US) 2020-02-05 — — EP disclosed
Send feedback